Design, Synthesis, Molecular Docking, and in vitro Anti-Inflammatory Evaluation of Novel Benzimidazole Derivatives as Potential COX-2 Inhibitors
International Journal of Pharmaceutical Investigation · 11.06.2026 · 16 (3) · 1056-1063
DOI: 10.5530/ijpi.20260097 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical Investigation, online erschienen am 11.06.2026. Verfasst von Neha Shyam Bora und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Bora, N. S., Bhosale, M. S., Balsane, A. S., Dhamak, V. M., Bhor, R. J., Dattatraya, S. M., & KeshavTambe, S. (2026). Design, Synthesis, Molecular Docking, and in vitro Anti-Inflammatory Evaluation of Novel Benzimidazole Derivatives as Potential COX-2 Inhibitors. International Journal of Pharmaceutical Investigation, 16(3), 1056-1063. https://doi.org/10.5530/ijpi.20260097
Vancouver
Bora NS, Bhosale MS, Balsane AS, Dhamak VM, Bhor RJ, Dattatraya SM, et al. Design, Synthesis, Molecular Docking, and in vitro Anti-Inflammatory Evaluation of Novel Benzimidazole Derivatives as Potential COX-2 Inhibitors. International Journal of Pharmaceutical Investigation. 2026;16(3):1056-1063. doi:10.5530/ijpi.20260097
BibTeX
@article{Bora2026,
author = {Bora, Neha Shyam and Bhosale, Mayur Shivaji and Balsane, Amol Sambhaji and Dhamak, Vikrant Murlidhar and Bhor, Rohit Jaysing and Dattatraya, Sagar Magar and KeshavTambe, Sanket},
title = {Design, Synthesis, Molecular Docking, and in vitro Anti-Inflammatory Evaluation of Novel Benzimidazole Derivatives as Potential COX-2 Inhibitors},
journal = {International Journal of Pharmaceutical Investigation},
year = {2026},
volume = {16},
number = {3},
pages = {1056--1063},
doi = {10.5530/ijpi.20260097}
}
EUVIMED